KLOW Peptide Blend (80mg)

Four-Peptide Recovery & Inflammation Research Blend

KLOW Peptide Blend (80mg) will be supplied by Aussie Peptides with fast domestic shipping to all states and territories.

KLOW is a separate product to GLOW, not a variant. Where GLOW is positioned around dermal structural repair, KLOW extends the concept toward broader anti-inflammatory and recovery research. It combines GHK-Cu, BPC-157, TB-500, and KPV in one vial for research protocols studying tissue regeneration, immune modulation, gut-barrier function, and recovery.

The 80mg four-peptide stack: GHK-Cu is studied for collagen signalling and tissue remodelling; BPC-157 and TB-500 are studied for angiogenesis, connective-tissue repair, and cellular migration; KPV shifts the blend toward anti-inflammatory and immune-modulating research, including gut-lining models.

Key Research Areas

• Tissue Regeneration — Studied across collagen signalling, repair-cell mobilisation, angiogenesis, and structural remodelling
• Inflammatory Signalling — BPC-157 and KPV studied for anti-inflammatory and immune-modulating activity
• Gut-Skin Axis Research — KPV relevant to barrier integrity and gut-linked inflammatory models
• Connective Tissue Models — BPC-157 and TB-500 studied across muscle, tendon, ligament, and soft-tissue repair models
• Dermal Research — GHK-Cu studied for collagen, elastin, and dermal structural protein synthesis

Supplied as lyophilized powder at high purity, verified by HPLC and mass spectrometry. 80mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.